The administration of FcεRI (MAR-1) mAb in Foxp3DTR melanoma-bearing mice depleted basophils and abrogated the recruitment of CD8+ T cells thus preventing the rejection of melanoma. This evidence concerns the gene FCER1A and melanoma.